João A Oliveira-da-Silva Selected Research

Enzymes

6/2022

Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

João A Oliveira-da-Silva Research Topics

Disease

26	Visceral Leishmaniasis (Kala Azar) 06/2022 - 12/2019
14	Infections 07/2022 - 01/2020
9	Leishmaniasis 06/2022 - 12/2019
4	Coinfection 12/2021 - 01/2020
2	HIV Infections (HIV Infection) 12/2021 - 11/2021
2	Neglected Diseases 06/2020 - 01/2020
1	Drug-Related Side Effects and Adverse Reactions 02/2022
1	COVID-19 01/2022
1	Paracoccidioidomycosis (South American Blastomycosis) 12/2021
1	Chagas Disease (American Trypanosomiasis) 12/2021
1	Tuberculosis (Tuberculoses) 12/2021
1	Leprosy (Hansen's Disease) 12/2021
1	Parasitic Diseases (Parasitic Disease) 02/2021
1	Heart Diseases (Heart Disease) 01/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 06/2022 - 12/2019
8	Recombinant ProteinsIBA 06/2022 - 01/2020
6	VaccinesIBA 06/2022 - 01/2020
6	AntigensIBA 12/2021 - 12/2019
5	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 06/2022 - 03/2020
4	AntibodiesIBA 01/2022 - 12/2019
3	MicellesIBA 07/2022 - 01/2020
3	Pyridoxal KinaseIBA 12/2020 - 01/2020
2	Recombinant Fusion ProteinsIBA 12/2021 - 08/2021
2	Peptides (Polypeptides)IBA 12/2021 - 11/2021
2	Immunoglobulin G (IgG)IBA 02/2021 - 01/2020
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2021 - 01/2020
2	Interleukin-12 (IL 12)IBA 02/2021 - 01/2020
2	CardenolidesIBA 01/2021 - 01/2021
2	DNA VaccinesIBA 12/2020 - 01/2020
2	Synthetic Vaccines (Recombinant Vaccines)IBA 06/2020 - 01/2020
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 06/2020 - 01/2020
1	SaltsIBA 07/2022
1	quinolineIBA 07/2022
1	ImmunosorbentsIBA 06/2022
1	EnzymesIBA 06/2022
1	NaphthoquinonesIBA 02/2022
1	Poloxamer (Poloxamer 407)IBA 01/2022
1	Guanosine Triphosphate (GTP)IBA 01/2022
1	GTP-Binding Proteins (G-Protein)IBA 01/2022
1	N 30IBA 12/2021
1	EpitopesIBA 11/2021
1	Acarbose FDA LinkGeneric 06/2021
1	Pharmaceutical PreparationsIBA 02/2021
1	Virulence Factors (Pathogenicity Factors)IBA 02/2021
1	A-Form DNA (A-DNA)IBA 02/2021
1	Ivermectin (Mectizan)FDA Link 02/2021
1	SaponinsIBA 02/2021
1	miltefosine (Impavido)IBA 01/2021
1	Digitoxin FDA Link 01/2021
1	Therapeutic UsesIBA 01/2021
1	DigitoxigeninIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Liposomes (Liposome)IBA 06/2020
1	Leishmania infantum amastin proteinIBA 01/2020
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2020
1	Clioquinol (Vioform)FDA Link 01/2020
1	ProhibitinsIBA 01/2020
1	UCON 50-HB-5100 (F127)IBA 01/2020
1	NitritesIBA 01/2020
1	Staphylococcal Protein A (Protein A)IBA 12/2019

Therapy/Procedure

2	Therapeutics 02/2022 - 12/2019
1	Aftercare (After-Treatment) 12/2019